Home > Subjects > Interdisciplinary Research & Study > Center for Biomedical Innovation

Center for Biomedical Innovation

Launched in 2005, the MIT Center for Biomedical Innovation (CBI) is a collaboration among the MIT Schools of Engineering, Management, and Science, and the Harvard-MIT Division of Health Sciences and Technology (HST). CBI's mission is to generate and disseminate high-impact systemic solutions that enhance efficacy, safety, and quality of patient care worldwide.

CBI conducts collaborative research within a "safe haven" environment, with participation from MIT and Harvard faculty and students as well as the active involvement of a network of academic, industry, and government experts. Our primary areas of interest include:

• Safety assessment—Improve predictability in preclinical and clinical assessment and postmarketing surveillance through better use of informatics tools and data
• Research and development redesign—Enhance productivity through new collaboration and research models
• Manufacturing and distribution systems—Rationalize the supply chain and implement quality-by-design
• Risk management (economic and regulatory)—Apply systematic approaches that anticipate evolution in stratified medicine, regulatory change, and reimbursement

CBI also offers graduate courses and sponsors lectures focused on strategies for leading biomedical innovation. This portfolio of educational initiatives is designed to address the need for scientific, technical, and managerial expertise required for innovating in the healthcare industries.

For more information, contact the Center for Biomedical Innovation, Room NE20-382, 617-253-0257, fax 617-253-0257, cbi@mit.edu.

http://web.mit.edu/cbi/

 

need help?  |  change log  |  back to top